 |
 |
 |
 |
 |
|
            |
Basic Immunology in Medicine: Update 2008
Course Agenda
| 8:30 – 8:45 am | Introduction and overview – Abul Abbas, MD |
| 8:45 – 9:45 am | Antigen presentation – Hidde Ploegh, PhD |
| 9:45 – 10:15 am | Break |
| 10:15 – 11:15 am | Innate Immunity – Andrew Lichtman, MD, PhD |
| 11:15 am – 12:15 pm | T cell activation – Abul Abbas, MD |
| 12:15 – 1:15 pm | Lunch |
| 1:15 – 2:15 pm | Effector T Cells – Andrew Lichtman, MD, PhD |
| 2:15 – 3:15 pm | B cells – Hidde Ploegh, PhD |
| 3:15 – 3:45 pm | Break |
| 3:45 – 4:45 pm | Tolerance and autoimmunity – Abul Abbas, MD |
Continuing Medical Education Credit
This activity was planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the A. Webb Roberts Center for Continuing Education of Baylor Health Care System, Dallas, and the Federation of Clinical Immunology Societies. The A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System, Dallas, is accredited by the ACCME to provide continuing medical education for physicians.The A. Webb Roberts Center for Continuing Education of Baylor Health Care System, Dallas, designates this educational activity for 6 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Learning Objectives
At the conclusion of the activity, the participant should be able to:- Describe the major advances in basic immunology that are most relevant to human diseases, and the unresolved issues and future challenges.
- Recognize the fundamental mechanisms underlying immunologic diseases and the commonality among diverse organ specific disease states.
- Identify the basic principles underlying therapeutic modulation of the immune system, and the mechanisms of action of the major classes of immune modulators.
- Critically evaluate the medical literature reporting advances pertinent to immune diseases and immunotherapies.
- Explain the rationale for use of new immunodiagnostic and immunotherapeutic modalities in patients.
© 2008 FOCIS